Dr. Bright Pan Zhou, MD, MS

Dr. Zhou practices at Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD in Los Angeles, California.

Dr. Zhou's NPI, 1427636125, was assigned on April 1, 2021. Dr. Zhou graduated from Stanford University School Of Medicine in 2021. Dr. Zhou holds California license A183694.

Dr. Zhou's primary practice is Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD, at 1450 San Pablo St, Los Angeles, CA 90033.

Dr. Zhou's primary practice is Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD in Los Angeles, California. Dr. Zhou is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Zhou to 2 more group practices and clinics, 2 medical groups and 1 other site, each named with a free account. Dr. Zhou's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhou practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Zhou's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Zhou is board certified in family medicine by the American Board of Family Medicine. Dr. Zhou is licensed in California.

CMS data shows 100 Medicare services from Dr. Zhou across 3 procedure codes in 2024, for 41 Medicare patients. Medicare paid $7,091 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Dr. Zhou in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhou's median patient age at 45, with 59% women.

In 2024, Dr. Zhou wrote 279 Medicare Part D claims for 72 patients. 90% of them were for generic drugs. CMS names the drug for 113 of them, across 6 drugs with 11 or more claims each, at $568 in total drug cost. In 2023, CMS named 176 claims across 8 drugs.

Dr. Zhou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhou as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Zhou, published from 2021 to 2023. The most frequent topics are Students, Medical. Dr. Zhou has published most often in Acad Med. Dr. Zhou's most frequent co-authors are Sandrene Janice Cassells, MD, Alan K. Louie, MD and Torsten Jacob Rotto, MD.

Dr. Zhou graduated from Stanford University School Of Medicine in 2021.

Dr. Zhou is in network with 3 carriers, including United Healthcare, Blue Cross and Blue Shield of Kansas City and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.